Oak Street Health’s (OSH) “Market Perform” Rating Reaffirmed at TD Cowen

Oak Street Health (NYSE:OSH – Get Rating)‘s stock had its “market perform” rating reiterated by investment analysts at TD Cowen in a research note issued on Wednesday, Benzinga reports. They presently have a $39.00 target price on the stock, up from their prior target price of $34.00. TD Cowen’s target price suggests a potential upside of 9.70% from the stock’s current price.

Other equities analysts have also issued research reports about the company. UBS Group cut their target price on Oak Street Health from $28.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 6th. Piper Sandler lowered Oak Street Health from an “overweight” rating to a “neutral” rating and cut their target price for the company from $47.00 to $39.00 in a research note on Wednesday, February 8th. SVB Leerink boosted their price target on Oak Street Health from $33.00 to $39.00 and gave the stock a “market perform” rating in a research note on Wednesday, February 8th. JPMorgan Chase & Co. lowered Oak Street Health from an “overweight” rating to a “neutral” rating and boosted their price target for the stock from $35.00 to $39.00 in a research note on Thursday, February 23rd. Finally, William Blair lowered Oak Street Health from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 9th. One equities research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Oak Street Health has a consensus rating of “Hold” and an average price target of $33.06.

Oak Street Health Price Performance

OSH stock opened at $35.55 on Wednesday. The business has a 50-day moving average price of $32.05 and a 200 day moving average price of $25.75. Oak Street Health has a 1-year low of $13.29 and a 1-year high of $35.70. The company has a market capitalization of $8.67 billion, a P/E ratio of -16.09 and a beta of 2.22.

Oak Street Health (NYSE:OSH – Get Rating) last posted its earnings results on Tuesday, February 28th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.58) by $0.02. Oak Street Health had a negative return on equity of 1,883.59% and a negative net margin of 23.57%. The company had revenue of $577.70 million for the quarter, compared to analyst estimates of $571.26 million. During the same quarter in the previous year, the firm earned ($0.62) earnings per share. The firm’s quarterly revenue was up 46.6% compared to the same quarter last year. On average, analysts anticipate that Oak Street Health will post -1.58 earnings per share for the current fiscal year.

Insider Activity at Oak Street Health

In related news, COO Brian Clem sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 3rd. The stock was sold at an average price of $24.02, for a total value of $120,100.00. Following the sale, the chief operating officer now owns 546,337 shares in the company, valued at $13,123,014.74. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Oak Street Health news, COO Brian Clem sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 3rd. The stock was sold at an average price of $24.02, for a total value of $120,100.00. Following the completion of the transaction, the chief operating officer now directly owns 546,337 shares of the company’s stock, valued at $13,123,014.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Geoffrey M. Price sold 122,985 shares of the business’s stock in a transaction that occurred on Wednesday, February 22nd. The shares were sold at an average price of $35.61, for a total value of $4,379,495.85. Following the completion of the transaction, the insider now directly owns 3,874,863 shares of the company’s stock, valued at $137,983,871.43. The disclosure for this sale can be found here. Insiders have sold a total of 683,247 shares of company stock worth $23,127,762 over the last quarter. Insiders own 11.40% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Signaturefd LLC lifted its holdings in Oak Street Health by 81.1% in the fourth quarter. Signaturefd LLC now owns 1,320 shares of the company’s stock valued at $28,000 after acquiring an additional 591 shares during the period. Heritage Wealth Management LLC acquired a new position in Oak Street Health in the second quarter valued at approximately $58,000. Captrust Financial Advisors raised its stake in shares of Oak Street Health by 114.5% during the 1st quarter. Captrust Financial Advisors now owns 2,688 shares of the company’s stock worth $72,000 after buying an additional 1,435 shares during the period. PNC Financial Services Group Inc. raised its stake in shares of Oak Street Health by 1,496.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 3,480 shares of the company’s stock worth $93,000 after buying an additional 3,262 shares during the period. Finally, State of Wyoming acquired a new position in shares of Oak Street Health during the 4th quarter worth approximately $99,000. 92.04% of the stock is owned by institutional investors and hedge funds.

About Oak Street Health

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.